C. Dinney

Publications692
h-index86
Citations25,894
Highly Influential Citations833
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • H. Grossman
  • 442 Publications • 25,353 Citations
  • S. Shariat
  • 1,773 Publications • 46,838 Citations
  • A. Kamat
  • 556 Publications • 11,655 Citations
  • D. McConkey
  • 383 Publications • 24,932 Citations
  • Publications
  • Influence
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Muscle-invasive bladder cancers (MIBCs) are biologically heterogeneous and have widely variable clinical outcomes and responses to conventional chemotherapy. We discovered three molecular subtypes of… Expand
  • 903
  • 71
  • PDF
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer
We conducted a genome-wide association study on 969 bladder cancer cases and 957 controls from Texas. For fast-track validation, we evaluated 60 SNPs in three additional US populations and validated… Expand
  • 230
  • 17
Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
MicroRNAs (miRNA) are small noncoding RNA molecules involved in a diversity of cellular functions. Although it has been reported that global suppression of the miRNA biogenesis pathway leads to… Expand
  • 246
  • 16
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer
Epithelial-to-mesenchymal transition (EMT) is a process that plays essential roles in development and wound healing that is characterized by loss of homotypic adhesion and cell polarity and increased… Expand
  • 307
  • 16
Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
PURPOSE We report stage specific followup guidelines based on our evaluation of the pattern of recurrence in 286 patients treated for local N0 or Nx renal cell carcinoma. MATERIALS AND METHODS We… Expand
  • 317
  • 14
Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus.
BACKGROUND The optimal management of patients with renal cell carcinoma with inferior vena cava tumor thrombus remains unresolved. Traditional approaches have included resection with or without the… Expand
  • 254
  • 13
Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer
Whole-genome analyses have revealed that muscle-invasive bladder cancers (MIBCs) are heterogeneous and can be grouped into basal and luminal subtypes that are highly reminiscent of those found in… Expand
  • 177
  • 13
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.
PURPOSE To evaluate ability of the University of California Los Angeles Integrated Staging System (UISS) to stratify patients with localized and metastatic renal cell carcinoma (RCC) into risk groups… Expand
  • 302
  • 12
Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival.
PURPOSE Since chronic inflammation contributes to tumorigenesis, we hypothesized that the risk and clinical outcome of bladder cancer (BC) might be modulated by genetic variations in inflammation… Expand
  • 146
  • 12
Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
Epidermal growth factor receptor (EGFR) regulates the growth and progression of human transitional cell carcinoma (TCC) of the bladder. We have shown that therapy targeting EGFR inhibited the growth… Expand
  • 432
  • 11
  • PDF
...
1
2
3
4
5
...